Comparative performance of first-void urine and self-collected vaginal swabs against clinician-collected cervical samples using 2 HPV real-time assays in Indian women
Authors:
- Rajeswari ARARajeswari A
- John Dickson Calvin DevadasanJDJohn Dickson Calvin Devadasan
- Vinotha ThomasVTVinotha Thomas
- Dhanya Susan ThomasDTDhanya Susan Thomas
- Anitha ThomasATAnitha Thomas
- Annie Prasanthi VijjeswarapuAVAnnie Prasanthi Vijjeswarapu
- Shiny NirupamaSNShiny Nirupama
- Karthick NithyanandhanKNKarthick Nithyanandhan
- Annarani JoseAJAnnarani Jose
- Susanne A. PulimoodSPSusanne A. Pulimood
- Leni GeorgeLGLeni George
- Anne Jennifer PrabhuAPAnne Jennifer Prabhu
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37
Abstract
To enhance participation of women in cervical cancer (CC) screening, we compared high-risk human papillomavirus (HR-HPV) DNA testing of first-void urine (FVU) and self-collected vaginal swabs (SCVSs) to the gold standard clinician collected cervical specimens (CCCSs). In this cross-sectional study, consecutive consenting women (n=295) identified for CC screening mainly from Gynaecology-Oncology out-patient clinics were enrolled from May to October 2024. All were educated to provide self-samples (FVU, SCVS) followed by CCCS. All samples were tested for HR-HPV by 2 real-time polymerase chain reaction assays: Alinity m HR-HPV assay and Allplex™ II HPV HR assay. Awareness of CC, its screening, prevention and acceptability of self-sampling methods were assessed through a questionnaire. All sample types showed identical concordance (93.9%)/discordance (6.1%) across both real-time assays. Using Alinity m, sensitivity and specificity of FVU vs. CCCS was similar to SCVS vs. CCCS, i.e., 83.3% (95% confidence interval [CI]=68.64%-93.03%) and 98% (95% CI=95.45%-99.36%) respectively. With Allplex, sensitivity and specificity of FVU vs. CCCS was 84.78% (95% CI=71.13%-93.66%) and 97.19% (95% CI=94.29%-98.86%) respectively; and that of SCVS vs. CCCS was 97.83% (95% CI=88.47%-99.94%) and 95.98% (95% CI=92.74%-98.06%) respectively. Majority were unaware of CC (86.4%), its screening (98.6%) or its prevention (96.9%). Majority of women (92%) preferred FVU for CC if screened at regular intervals. This study shows a favorable performance of FVU and SCVS in both assays. FVU is a scalable, non-invasive, acceptable and feasible alternative to CCCS, with the potential to intensify CC screening programs in low- and middle-income countries.Keywords
This publication has 29 references indexed in Scilit:
- Strategies and implementation outcomes of HPV-based cervical screening studies to prevent cervical cancer in India: A systematic reviewJournal of Cancer Policy, 2024
- Comparison of HPV DNA Detection in Self-Collected Urine and Vaginal SamplesIndian Journal of Gynecologic Oncology, 2024
- Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: A systematic reviewPreventive Medicine Reports, 2024
- Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screeningInternational Journal of Cancer, 2022
- Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and ManagementIndian Journal of Gynecologic Oncology, 2021
- A Study on Knowledge and Awareness of Cervical Cancer Among Females of Rural and Urban Areas of Haryana, North IndiaJournal of Cancer Education, 2020
- Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource settingClinical Microbiology and Infection, 2019
- HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized TrialJournal of General Internal Medicine, 2018
- Self-collected vaginal swabs for HPV screening: An exploratory study of rural Black Mississippi womenPreventive Medicine Reports, 2016
- Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV testJournal of Clinical Virology, 2014